389650 — NextBioMedical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for NextBioMedical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14,797	14,290	41,609	36,998
Net Total Accounts Receivable
Net Total Receivables	505	1,216	2,244	2,478
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17,521	17,968	46,888	43,267
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11,735	11,428	11,270	14,018
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	32,136	29,643	58,844	59,265
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30,968	33,786	11,884	8,044
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	32,390	35,544	13,653	11,158
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-254	-5,901	45,191	48,107
Total Liabilities & Shareholders' Equity	32,136	29,643	58,844	59,265
Total Common Shares Outstanding